TransMedics Group Inc.
Organization details
- Legal name
- TransMedics Group Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Massachusetts
- Headquarters city
- Andover
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TMDX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001756262
Board of directors
-
David Weill · DirectorSince 2023
-
Edward M. Basile · DirectorSince 2023
-
Edwin M. Kania Jr. · DirectorSince 2023
-
James R. Tobin · DirectorSince 2023
-
Merilee Raines · DirectorSince 2023
-
Stephanie Lovell · DirectorSince 2023
-
Thomas James Gunderson · DirectorSince 2023
-
Waleed H. Hassanein · Director · President & CEOSince 2023
Chief executives
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
93.1%
-
98.1%
-
98.2%
-
98.4%
-
99.2%
-
99.4%
-
99.5%
-
99.5%
Board connections
3 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
Globus Medical Inc. Same sectorvia James R. Tobin
-
Merit Medical Systems Inc. Same sectorvia Thomas James Gunderson
-
Ocular Therapeutix Inc. Same sectorvia Merilee Raines
- via Merilee Raines
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,109,408
- 2 purchases by 2 insiders
- Sold, last 12 months
- $4,332,690
- 11 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 28, 2026 | Araujo Fernando N. Officer (See Remarks) | Grant or award | +22,969 | — | — |
| Sep 11, 2026 | David Weill Director | Open-market purchase | +1,336 | $81.63 | $109,058 |
| Aug 17, 2026 | James R. Tobin Director | Gift | −18,000 | — | — |
| Jul 10, 2026 | Corcoran Nicholas Officer (See remarks) | Grant or award | +11,727 | — | — |
| Jul 10, 2026 | Waleed H. Hassanein Director, Officer (President & CEO) | Grant or award | +49,669 | — | — |
| Jul 10, 2026 | Hernandez Gerardo Officer (Chief Financial Officer) | Grant or award | +17,246 | — | — |
| Jun 15, 2026 | Thomas James Gunderson Director | Option exercise | +19,285 | $2.21 | $42,620 |
| Jun 15, 2026 | Thomas James Gunderson Director | Open-market sale | −9,624 | $75.06 | $722,377 |
| May 20, 2026 | Stephanie Lovell Director | Grant or award | +2,922 | — | — |
| May 20, 2026 | David Weill Director | Grant or award | +2,922 | — | — |
| May 20, 2026 | Merilee Raines Director | Grant or award | +2,922 | — | — |
| May 20, 2026 | Thomas James Gunderson Director | Grant or award | +2,922 | — | — |
| May 20, 2026 | Edward M. Basile Director | Grant or award | +2,922 | — | — |
| May 20, 2026 | James R. Tobin Director | Grant or award | +2,922 | — | — |
| May 20, 2026 | Edwin M. Kania Jr. Director | Grant or award | +2,922 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about TransMedics Group Inc.
Who is the CEO of TransMedics Group Inc.?
Waleed H. Hassanein is TransMedics Group Inc.'s President & CEO.
How many directors are on TransMedics Group Inc.'s board?
TransMedics Group Inc.'s board has 8 directors: David Weill, Edward M. Basile, Edwin M. Kania Jr., James R. Tobin, Merilee Raines, Stephanie Lovell, Thomas James Gunderson and Waleed H. Hassanein.
Are TransMedics Group Inc. insiders buying or selling shares?
Over the last 12 months, TransMedics Group Inc. insiders bought $1.1 million of shares in 2 purchases and sold $4.3 million of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="transmedics-group-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.